Bernstein Harold - Insider Non-Derivative Transactions at Maze Therapeutics, Inc. (MAZE) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Dec 29, 2025, Bernstein Harold's relationship to Maze Therapeutics, Inc. (MAZE) is Officer (President, R&D & CMO), and currently has 45,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other MAZE insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Bernstein Harold - Insider Non-Derivative Transactions of MAZE Common Stock

Bernstein Harold - Insider Non-Derivative Transactions at MAZE

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 30, 2025	Sell -- (Common Stock)	17200	40.93	0
Dec 30, 2025	Sell -- (Common Stock)	27800	40.34	17200
Dec 30, 2025	M -- (Common Stock)	45000	10.42	45000